Chad Gassert - 26 Feb 2026 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
02 Mar 2026, 17:58:22 UTC
Prior SEC filing
17 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Chad Gassert, by attorney-in-fact Meredith W. Cook

Key filing fact

Chad Gassert filed Form 4 for ANI PHARMACEUTICALS INC (ANIP) on 02 Mar 2026.

Key facts

  • This page summarizes Chad Gassert's Form 4 filing for ANI PHARMACEUTICALS INC (ANIP).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Mar 2026, 17:58.

Change

  • Previous filing in this sequence was filed on 17 Feb 2026.
  • Current net transaction value: +$693,468.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001871002 Primary reporting owner

Gassert Chad

Relationship
SVP - CORP. DEV. & STRATEGY
Address
C/O ANI PHARMACEUTICALS, INC., 210 MAIN STREET WEST, BAUDETTE
Signature
/s/ Chad Gassert, by attorney-in-fact Meredith W. Cook
Signature date
02 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ANIP transaction

Common Stock

Award

Transaction value
$857,599
Shares
+11,116
Change %
+17%
Price
$77.15
Shares after
77,137
Date
26 Feb 2026
Ownership
Direct
Footnotes
F1
ANIP transaction

Common Stock

Tax liability

Transaction value
$164,132
Shares
-2,221
Change %
-2.9%
Price
$73.90
Shares after
74,916
Date
28 Feb 2026
Ownership
Direct
Footnotes
F2
ANIP holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
158,490
Date
26 Feb 2026
Ownership
Held by Chali Properties LLC
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 26, 2026.

Footnote F2

Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,342 shares of restricted stock, the grant of which was previously reported.

Footnote F3

The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .